BIO
Bio-Rad Laboratories IncNYSEHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$7.53B
P/E Ratio
10.01
EPS
$27.86
Beta
1.16
52W High
$343.12
52W Low
$211.43
50-Day MA
$279.12
200-Day MA
$288.52
Dividend Yield
—
Profit Margin
29.40%
Forward P/E
27.62
PEG Ratio
4.01
About Bio-Rad Laboratories Inc
Bio-Rad Laboratories, Inc. is an American developer and manufacturer of specialized technological products for the life science research and clinical diagnostics markets.
Fundamentals
| Revenue (TTM) | $2.58B |
| Gross Profit (TTM) | $1.34B |
| EBITDA | $431.60M |
| Operating Margin | 8.87% |
| Return on Equity | 10.80% |
| Return on Assets | 1.67% |
| Revenue/Share (TTM) | $94.69 |
| Book Value | $276.16 |
| Price-to-Book | 1.01 |
| Price-to-Sales (TTM) | 2.92 |
| EV/Revenue | 2.862 |
| EV/EBITDA | 6.11 |
| Quarterly Earnings Growth (YoY) | -83.00% |
| Quarterly Revenue Growth (YoY) | 3.90% |
| Shares Outstanding | $21.92M |
| Float | $21.13M |
| % Insiders | 16.20% |
| % Institutions | 90.34% |
Analyst Ratings
Consensus ($321.25 target)
2
Buy3
HoldData last updated: 4/7/2026